Collectively, MACROH2A1 was revealed to be a molecule that increased in the order of healthy controls, non-critical cases, and critical cases, and that was able to distinguish between refractory and non-refractory, critical and non-critical, and we considered this protein as the most probable biomarker for predicting refractory COVID-19. This evidence concerns the gene MACROH2A1 and COVID-19.